(COCH2,A), 47.9 (COCH2,B), 12.21 (5-CH3,A), 12.18 (5-CH3,B),
11.81 (5¢¢¢-CH3,B), 11.77 (5¢¢¢-CH3,A); HRMS MALDI FT-MS
m/z 760.2556 ([M + Na]+, calcd C39H39N5O10·Na+ 760.2589).
orated, and the resulting residue was purified by silica-gel column
chromatograpy (25% acetone in petroleum ether (v/v)), affording
a rotameric and diastereomeric mixture of phosphoramidite 4a as
a colorless foam (298 mg, 86%). 31P NMR (121 MHz, CDCl3):
d 150.9, 150.4, 150.2, 149.0 ppm. HRMS MALDI FT-MS m/z
(M + Na+) found 960.3646 calc. 960.3668.
1-(2-Amino-2-N-(6-N-benzoyladenin-9-ylacetyl)-3-O-(2-cyano-
ethoxy(diisopropylamino)phosphinoxy)-2-deoxy-5-O-4,4¢-dime-
thoxytrityl-2-N,4-C-methylene-b-D-ribofuranosyl)thymine (4b).
Phosphoramidite 4b was obtained from amide 3a (327 mg,
0.38 mmol) as a colorless foam (339 mg, 85%) in a similar manner
as phosphoramidite 4a except for the column chromatography
(50% acetone in petroleum ether (v/v)). 31P NMR (CDCl3): d
151.2, 150.7, 150.5, 149.1 ppm. HRMS MALDI-FT MS m/z
(M + Na+) found 1073.4035 calc. 1073.4045.
1-(2-Amino-3-O-(2-cyanoethoxy(diisopropylamino)phosphin-
oxy)-2-deoxy-5-O-4,4¢-dimethoxytrityl-2-N,4-C-methylene-2-N-
phenylacetyl-b-D-ribofuranosyl)thymine (4c). Phosphoramidite
4c was obtained from amide 3c (264 mg, 0.38 mmol) as a colorless
foam (220 mg, 65%) in a similar manner as phosphoramidite 4a
except for the column chromatography (50% acetone in petroleum
ether (v/v)). 31P NMR (CDCl3): d 150.8, 150.3, 149.5 ppm. HRMS
MALDI-FT MS m/z (M + Na+) found 912.3680 calc. 912.3708.
1-(2-Amino-2-N-(6-N-benzoyladenin-9-ylacetyl)-2-deoxy-5-O-
4,4¢-dimethoxytrityl-2-N,4-C-methylene-b-D-ribofuranosyl)thym-
ine (3b). A rotameric mixture (~1:1.3 by 1H NMR) of ade-
nine derivative 3b was obtained from nucleoside 112 (286 mg,
0.50 mmol) and N-6-benzoyl(adenin-9-yl)acetic acid13 (2b, 178 mg,
0.60 mmol) as a colorless foam (421 mg, 99%) in a similar manner
as thymine derivative 3a except for the column chromatography
(0–7% MeOH in CH2Cl2 (v/v)). Physical data for rotameric mix-
ture: Rf = 0.5 (10% MeOH in CH2Cl2, (v/v)); 1H NMR (DMSO-
d6):18,19 d 11.56 (br s, 1.3H, ex, NHA/6¢¢¢-NHA), 11.39 (br s, 1H,
ex, NHB/6¢¢¢-NHB), 11.17 (br s, 2.3H, ex, NHA + B/6¢¢¢-NHA + B),
8.72 (s, 2.3H, H2¢¢¢A + B), 8.47 (s, 1.3H, H8¢¢¢A), 8.38 (s, 1H, H8¢¢¢B),
7.53–7.59 (m, 6.9H, H6A + B, ArA + B), 6.18 (d, J = 4.3 Hz, 1.3H,
ex, 3¢-OHA), 6.08 (d, J = 4.3 Hz, 1H, ex, 3¢-OHB), 5.75 (s, 1.3H,
H1¢A), 5.53 (s, 1H, H1¢B), 5.48 (d, J = 17.0 Hz, 1.3H, COCH2,A,a),
5.30 (d, J = 17.0 Hz, 1.3H, COCH2,A,b), 5.28 (d, J = 17.2 Hz,
1H, COCH2,B,a), 5.20 (d, J = 17.2 Hz, 1H, COCH2,B,b), 3.74–
3.77 (m, 15.8H, OCH3,A + B, H5¢¢B), 1.54 (s, 3.9H, 5-CH3,A), 1.51 (s,
3H, 5-CH3,B); 13C NMR (DMSO-d6): d 165.5 (COPhA + B), 165.2
(COCH2,A), 165.1 (COCH2,B), 151.5 (C2¢¢¢A/B), 151.4 (C2¢¢¢A/B),
145.6 (C8¢¢¢A), 145.5 (C8¢¢¢B), 134.3 (C6B), 134.1 (C6A), 86.4 (C1¢A),
86.0 (C1¢B), 55.1 (OCH3,A + B), 44.6 (COCH2,A), 44.3 (COCH2,B),
12.29 (5-CH3,A), 12.26 (5-CH3,B); HRMS MALDI FT-MS m/z
873.2943 ([M + Na]+, calcd C46H42N8O9·Na+ 873.2967).
Synthesis of oligonucleotides containing “double-headed” LNA
Syntheses of modified ONs were performed on 0.2 mmol scale
using an automated DNA synthesizer, using standard conditions
for unmodified phosphoramidites. Incorporation of “double-
headed” 2¢-amino-LNA thymine monomers was carried out by a
manual coupling protocol, using extended coupling time (20 min)
and 1H-tetrazole as activator. Stepwise coupling yields were >99%
for unmodified phosphoramidites and approximately 95% for
modified phosphoramidites. After deprotection and cleavage from
the solid support (32% aq. NH3, 12 h, 55 ◦C), the oligonucleotides
were purified by RP-HPLC, and their purity (>80%) and compo-
sition verified by IE-HPLC and MALDI-MS analysis (Table S1,
see ESI†), respectively.
1-(2-Amino-2-deoxy-5-O-4,4¢-dimethoxytrityl-2-N,4-C-methyl-
ene-2-N-phenylacetyl-b-D-ribofuranosyl)thymine (3c). A rota-
1
meric mixture (~1:1.6 by H NMR) of phenyl derivative 3c was
obtained from nucleoside 1 (286 mg, 0.50 mmol) and phenylacetic
acid (2c, 82 mg, 0.60 mmol) as a colorless foam (303 mg, 88%) in
a similar manner as thymine derivative 3a except for the column
chromatography (0–5% MeOH in CH2Cl2 (v/v)). Rf = 0.6 (10%
MeOH in CH2Cl2, (v/v)); 1H NMR (DMSO-d6):18,19 d 11.50 (br s,
1.5H, ex, NHA), 11.39 (br s, 1H, ex, NHB), 7.57 (s, 1H, H6B),
7.54 (s, 1.5H, H6A), 5.99 (d, J = 4.2 Hz, 1.5H, ex, 3¢-OHA),
5.96 (d, J = 4.1 Hz, 1H, ex, 3¢-OHB), 5.53 (s, 1.5H, H1¢A), 5.40
(s, 1H, H1¢B), 3.77 (s, 3H, COCH2,A), 3.74 (s, 15H, OCH3,A + B),
3.63 (d, J = 15.8 Hz, 1H, COCH2,B,a), 3.59 (d, J = 15.8 Hz,
Thermal denaturation studies
1H, COCH2,B,b), 1.51 (s, 4.5H, 5-CH3,A), 1.47 (s, 3H, 5-CH3,B); 13
C
Melting temperatures (Tm values) were determined as the max-
imum of the first derivative of◦ the melting curve (A260 vs.
temperature; temperature ramp 1 C/min) and were recorded in
10 mM sodium phosphate buffer (100 mM NaCl, 0.1 mM EDTA,
adjusted to pH 7.0 by 10 mM NaH2PO4/5 mM Na2HPO4) using
1.0 mM concentrations of the two complementary strands. The
reported thermal denaturation temperatures are an average of at
least two measurements within 0.5 ◦C.
NMR (DMSO-d6): d 169.3 (COCH2,A), 169.2 (COCH2,B), 134.4
(C6B), 134.1 (C6A), 86.8 (C1¢A), 86.2 (C1¢B), 55.0 (OCH3,A + B), 39.9
(COCH2,A + B, overlap with DMSO-d6), 12.3 (5-CH3,A), 12.2 (5-
CH3,B); HRMS MALDI FT-MS m/z 712.2623 ([M + Na]+, calcd
C40H39N3O8·Na+ 712.2629).
General procedure for synthesis of 4.
1-(2-Amino-3-O-(2-cyanoethoxy(diisopropylamino)phosphin-
oxy)-2-deoxy-5-O-4,4¢-dimethoxytrityl-2-N,4-C-methylene-2-N-
(thymin-1-ylacetyl)-b-D-ribofuranosyl)thymine (4a). Amide 3a
(275 mg, 0.37 mmol) was dried by co-evaporation with dry
dichloroethane, then dissolved in dichloromethane (5 ml). N,N¢-
diisopropylethylamine (129 ml, 0.74 mmol) and O-(2-cyanoethyl)-
N,N¢-diisopropyl-aminophosphorochloridite (123 ml, 0.55 mmol)
were added at 0 ◦C. After stirring at rt for 2 h, absolute
EtOH was added (2 ml). The reaction mixture was diluted with
dichloromethane (50 ml) and washed with phosphate buffer (5 ¥
50 ml, pH 7.0). Organic layer was dried with Na2SO4, then evap-
Molecular modeling
Unmodified duplex 5¢-d(GTG AAT AGC C):3¢-d(CAC TTA
TCG G) was built having standard B-type helical geometry and
subsequently modified to duplex 5¢-d(GTG AATL AGC C):3¢-
T
d(CAC TTA TLACG G) in MacroModel V9.1.14 The charge
of the phosphodiester backbone was neutralized with sodium
ions, which were placed 3.0 A from the non-bridging oxygen
atoms. Monte Carlo conformational search was performed, with
torsional sampling of the N2¢-functionalities (for monomer TL
˚
,
T
1796 | Org. Biomol. Chem., 2009, 7, 1793–1797
This journal is
The Royal Society of Chemistry 2009
©